Question 1

Does Ubs own CNSP stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 1,461 shares of CNSP (CNS Pharmaceuticals), worth $6,983.

Question 2

How many shares of CNSP does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 1,461 shares of CNSP (CNS Pharmaceuticals).

Question 3

What is Ubs' CNSP position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' CNSP position is worth $6,983.

Question 4

Is Ubs buying or selling CNSP?

Accepted Answer

In Q2 2026, Ubs increased its CNSP position by 732 shares (+100.4%).

Question 5

When did Ubs first buy CNSP?

Accepted Answer

Ubs first reported CNSP in its Q3 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1,461	+100.4%	$6,983	0.0%	$4.78	18
2026-Q1	Increased	729	+19.3%	$1,742	0.0%	$2.39	9
2025-Q4	Decreased	611	-94.2%	$3,208	0.0%	$5.25	0
2025-Q3	New	10,520	-	$94,680	0.0%	$9.00	33

CNSP4 quarters

CNSP
4 quarters